IXCHIQ Purple Book BLA 125777
- BLA number
- 125777
- Proprietary names
- IXCHIQ
- Proper names
- Chikungunya Vaccine, Live
- Applicant
- Valneva Austria GmbH
- Center
- CBER
- First observed release
- 2023-11-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | IXCHIQ | Chikungunya Vaccine, Live | 351(a) | 3.0 log10 TCID | For Injection | Intramuscular | Single-Dose Vial | Disc | Revoked | 2023-11-09 | |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2026-02-01 | U | 001 | IXCHIQ | 351(a) | Disc | Valneva Austria GmbH |
| 2023-11-01 | U | 001 | IXCHIQ | 351(a) | Rx | Valneva Austria GmbH |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2026-02-01 | 001 | IXCHIQ | 351(a) | Disc | Revoked | 2023-11-09 |
| 2023-11-01 | 001 | IXCHIQ | 351(a) | Rx | Licensed | 2023-11-09 |